| |
| |
|
| Insider
Information: |
Malley Thomas |
| Relationship: |
|
| City: |
Denver |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
430,306 |
|
|
Indirect Shares
|
211,524 |
|
|
| Direct
Value |
$10,886,977 |
|
|
|
Indirect Value
|
$4,029,065 |
|
|
| Total
Shares |
641,830 |
|
|
| Total
Value |
$14,916,042 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 111.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Synageva BioPharma Corp |
GEVA |
Director |
2015-06-22 |
0 |
|
0 |
Premium* |
|
|
Puma Biotechnology Inc |
PBYI |
Director |
2012-10-24 |
156,551 |
2011-11-18 |
0 |
Premium* |
|
|
Tempest Therapeutics, Inc |
TPST |
Director |
2017-06-13 |
204,981 |
|
0 |
Premium* |
|
|
Kura Oncology Inc |
KURA |
Director |
|
0 |
2023-06-16 |
139,557 |
Premium* |
|
|
Beigene Ltd |
BGNE |
Director |
2022-06-22 |
63,774 |
2016-11-23 |
0 |
Premium* |
|
|
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
|
2023-06-29 |
5,000 |
2023-06-29 |
71,967 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KNSA |
Kiniksa Pharmaceuticals, ... |
|
– • – |
2023-06-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| KURA |
Kura Oncology Inc |
Director |
– • – |
2023-06-16 |
4 |
B |
$11.50 |
$575,000 |
I/I |
50,000 |
139,557 |
2.1 |
% |
|
| BGNE |
Beigene Ltd |
Director |
– • – |
2022-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
16,692 |
33,774 |
0 |
- |
|
| BGNE |
Beigene Ltd |
Director |
– • – |
2021-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
7,800 |
17,082 |
0 |
- |
|
| BGNE |
Beigene Ltd |
Director |
– • – |
2018-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
9,290 |
9,290 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Director |
– • – |
2018-05-29 |
4 |
A |
$0.00 |
$0 |
I/I |
71,967 |
71,967 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2017-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
7,873 |
204,981 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2017-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
7,085 |
197,108 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2016-12-30 |
4 |
A |
$1.53 |
$13,250 |
D/D |
8,660 |
190,023 |
0 |
- |
|
| BGNE |
Beigene Ltd |
Director |
– • – |
2016-11-23 |
4 |
B |
$32.00 |
$960,000 |
D/D |
30,000 |
30,000 |
2.39 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2016-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,850 |
181,363 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2016-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,543 |
179,513 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2016-06-01 |
4 |
A |
$7.00 |
$350,000 |
D/D |
50,000 |
176,970 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2016-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,396 |
126,970 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2015-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,356 |
125,574 |
0 |
- |
|
| KURA |
Kura Oncology Inc |
Director |
– • – |
2015-11-10 |
4 |
B |
$8.00 |
$400,000 |
I/I |
50,000 |
89,557 |
2.1 |
- |
|
| KURA |
Kura Oncology Inc |
Director |
– • – |
2015-10-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
39,557 |
|
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2015-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,560 |
124,218 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2015-06-30 |
4 |
A |
$28.93 |
$13,250 |
D/D |
458 |
122,658 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
Director |
– • – |
2015-06-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(46,901) |
0 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2015-04-08 |
4 |
B |
$28.50 |
$142,500 |
D/D |
5,000 |
122,200 |
2.39 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2015-03-31 |
4 |
A |
$34.73 |
$13,232 |
D/D |
381 |
117,200 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2015-01-13 |
4 |
B |
$50.00 |
$1,750,000 |
D/D |
35,000 |
116,819 |
2.39 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2013-03-18 |
4 |
B |
$9.00 |
$450,000 |
D/D |
50,000 |
81,819 |
2.39 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2012-10-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
31,819 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
